Earnings Call · Q4 FY2024·2025-02-13

Q4 24EPS +100.00%*·Rev n/aQ3 24EPS -28.21%·Rev n/aQ2 24EPS +100.00%*·Rev n/aQ1 24EPS +74.60%·Rev n/a⚠ consensus missing

ALNYLAM PHARMACEUTICALS, INC. ALNY

Christine Lindenboom — Chief Corporate Communications Officer

Yvonne Greenstreet — Chief Executive Officer

Tolga Tanguler — Chief Commercial Officer

Pushkal Garg — Chief Medical Officer

Jeff Poulton — Chief Financial Officer

+8.5%1d on move date+8.4% vs SPY3d+5.5%5d+3.5%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ALNY calls or request research access.

More ALNY calls Browse calls Request research access